30th week of 2011 patent applcation highlights part 35 |
Patent application number | Title | Published |
20110182945 | SEMI-ALLOGENIC ANTI-TUMOUR VACCINE WITH HLA HAPLO-IDENTICAL ANTIGEN-PRESENTING CELLS - The present invention relates to semi-allogeneic antigen-presenting cells into which proteins and/or peptides or RNA or DNA or cDNA, respectively, encoding said proteins and/or peptides which are overexpressed in tumor cells or which are derived from autologous tumor cells or different tumor cells or different tumor cell lines have been introduced. Furthermore the invention relates to methods for the generation of these semi-allogeneic antigen-presenting cells as well as to the use thereof in the treatment of tumor diseases. | 2011-07-28 |
20110182946 | Formation of Nanostructured Particles of Poorly Water Soluble Drugs and Recovery by Mechanical Techniques - The present invention provides a composition and method of forming an amorphous drug-loaded particle by forming one or more amorphous drug-loaded nanoparticles comprising one or more active agents stabilized by one or more polymers, desolvating the one or more amorphous drug-loaded nanoparticles to form one or more flocculated amorphous drug-loaded nanoparticles, filtering the one or more flocculated amorphous drug-loaded nanoparticles and drying the one or more flocculated amorphous drug-loaded nanoparticles to form amorphous drug-loaded particles. | 2011-07-28 |
20110182947 | HYDROGEL-DRIVEN DRUG DOSAGE FORM - A controlled release dosage form has a coated core with the core comprising a drug-containing composition and a water-swellable composition, each occupying separate regions within the core. The drug-containing composition comprises a low-solubility drug and a drug-entraining agent. The coating around the core is water-permeable, water-insoluble and has at least one delivery port therethrough. A variety of formulations having specific drug release profiles are disclosed. | 2011-07-28 |
20110182948 | METHOD FOR TREATING DISEASE CHARACTERIZED BY PLAQUE - The present invention relates to the use of a filamentous agent other than a filamentous bacteriophage to disaggregate aggregated proteins in plaque or to treat a patient suffering from or susceptible to a disease characterized by the presence of plaque. | 2011-07-28 |
20110182949 | STABILIZED TRANSDERMAL DRUG DELIVERY SYSTEM - A solid dispersion transdermal drug delivery system comprising a therapeutic agent in a stable amorphous form and a combination polymeric stabilizing and dispersing agent having a hydrogen bond-forming functional group, and a method of manufacturing these systems is provided. The weight ratio of the combination polymeric stabilizing and dispersing agent to the therapeutic agent is also disclosed. | 2011-07-28 |
20110182950 | COMBINATION OF BLOOD AND OF BIPHASIC CALCIUM PHOSPHATE CERAMIC PARTICLES - The invention relates to a biomaterial containing coagulated blood or coagulated bone marrow aspirate and biphasic calcium phosphate ceramic particles, to a production method thereof and to the use of same for the production of an implant that enables bone tissue regeneration. | 2011-07-28 |
20110182951 | Antimicrobial Coatings Comprising A Complex of An Ionic Fluoropolymer and An Antimicrobial Counter-Ion - The present invention relates to an article comprising a substrate and a coating thereon comprising a complex of an ionic fluoropolymer and a counter-ionic agent comprising ions having antimicrobial activity, to a process for the production of a coating on a polymeric substrate comprising the steps of a) preparing a mixture of an ionic fluoropolymer or a precursor thereof and a counter-ionic agent comprising ions having antimicrobial activity or a precursor thereof and b) applying the mixture prepared in step a) onto the substrate, to the use of such articles for the manufacture of i.a. a garment, a filter element, a venting element or a protective enclosure, and to the use of a coating composition comprising a complex of an ionic fluoropolymer and a counter-ionic agent comprising ions having antimicrobial activity as an antimicrobial coating of a substrate. | 2011-07-28 |
20110182952 | DRUG DELIVERY FROM EMBOLIC AGENTS - A pharmaceutical composition for embolization of blood vessels, especially for benign tumours, comprises a polymeric embolic agent and, associated with the polymer in a releasable form, a local anaesthetic agent. The polymer is preferably in particulate form, such as in the form of microspheres. A suitable polymer Is a crosslinked polyvinyl alcohol polymer formed by the copolymerization of PVA macromer with other ethylenically unsaturated monomers. The composition provides a synergistic treatment for the symptoms of tumours such as uterine fibrioids, leading to size regression as well as pain relief. | 2011-07-28 |
20110182954 | ORALLY-ADMINISTERED AGENT - An orally-administered agent is provided. The orally-administered agent comprises an intestinal medicine-containing layer containing a medicine to be released in intestines and having surfaces; intestinal collapse-controlling layers provided directly or through an arbitrary layer on the surfaces of the intestinal medicine-containing layer, respectively, at least a part of the intestinal collapse-controlling layers being collapsed in the intestines, and each of the intestinal collapse-controlling layers having a surface opposite to the intestinal medicine-containing layer; and gel-forming layers provided directly or through an arbitrary layer on the sides of the surfaces of the intestinal collapse-controlling layers, respectively, wherein the gel-forming layers are swelled and gelatinized by absorbing water to form a gel. The intestinal collapse-controlling layers are constituted of a material containing an enteric material to be dissolved by being in contact with a body fluid in the intestines. The orally-administered agent according to the present invention can be swallowed with ease and can release a medicine at intended parts of a living body (in particular, within intestines). | 2011-07-28 |
20110182955 | WATER- AND ACTIVE INGREDIENT-CONTAINING GEL - The invention relates to a hydrogel formed from water, at least one gel former, at least one pharmaceutical active ingredient or cosmetic ingredient and, optionally, further auxiliaries and additives obtainable by a) mixing water and optionally including auxiliaries and additives when appropriate, b) adding the gel former and homogenizing the mixture, c) adding the pharmaceutical active ingredient or cosmetic ingredient and, optionally, ionic compounds which induce gel formation, and homogenizing the mixture, d) pouring out the mixture onto a support and e) cooling the mixture to form the hydrogel, where steps a) to d) are carried out at a temperature between 79 and 95° C. This hydrogel is suitable for administering cosmetic ingredients onto or via the skin or mucous membrane of a human, in particular in the form of a cosmetic face pack. | 2011-07-28 |
20110182956 | Porous, Dissolvable Solid Substrate and Surface Resident Coating Comprising Matrix Microspheres - The present invention relates to personal care compositions, especially those personal care compositions in the form of a personal care article that is a porous dissolvable solid substrate. The porous dissolvable solid substrate has a surface resident coating comprising a surface resident coating comprising from about 25% to about 70% of a starch derived material, from about 5% to about 60% of a cationic surfactant conditioner, and from about 5% to about 60% of a perfume, that can provide a consumer benefit. | 2011-07-28 |
20110182957 | CELLULOSICS FOR TISSUE REPLACEMENT - This invention relates to biomaterial compositions, methods and kits for producing hydrogels with tunable physico-chemical properties. Specifically, the invention relates to producing cellulosic hydrogels having optimized physico-chemical properties enabling support of cell growth or as replacement or filler for tissue repair, reconstruction or augmentation. | 2011-07-28 |
20110182958 | ANTIMICROBIAL COMPOSITIONS - An environmentally- and user-friendly, aqueous antimicrobial solution comprising effective amounts of hydrogen peroxide, glycolic acid, and at least one antimicrobially-active solvent chosen from benzyl alcohol and phenoxyethanol; concentrated versions of same; kits that can be used to make same; wipes containing same; and the use of same in a method of antimicrobial treatment of a surface contaminated with a microorganism (e.g. bacterial or fungal spore such as | 2011-07-28 |
20110182959 | REMOVABLE ANTIMICROBIAL COATING COMPOSITIONS CONTAINING ACID-ACTIVATED RHEOLOGY AGENT AND METHODS OF USE - A method is provided for controlling microorganisms comprising coating a surface with a removable, antimicrobial film-forming composition. More specifically, the removable, antimicrobial film-forming composition comprises at least one antimicrobial agent and at least one acid-activated rheology agent. | 2011-07-28 |
20110182960 | Antimicrobial Coating - The invention relates to methods for applying coatings comprising recombinant gelatin and an antimicrobial agent to a surface. In particular, the invention is concerned with methods for coating medical devices. The invention is also concerned with coated surfaces and medical devises, and compositions comprising gelatin and an antimicrobial agent. | 2011-07-28 |
20110182961 | OSTEOGENIC CELL DELIVERY MATRIX - Compositions and methods for augmenting bone formation by administering isolated human mesenchymal stem cells (hMSCs) within a matrix provided. By adding calcium and/or phosphate ions to the matrix, one may foster greater bone regeneration. | 2011-07-28 |
20110182962 | RESORBABLE MATRIX HAVING ELONGATED PARTICLES - Compression resistant matrices and methods are provided that have elongated particles embedded therein. The compression resistant matrices provide improved stability and mechanical strength and resists shifting, extrusion and rotation after implantation. In some embodiments, the matrices provided reduce or prevent surface compression of the implantable matrix which will cause unwanted increased amounts of growth factor (e.g., bone morphogenic protein) to leak from the matrix. | 2011-07-28 |
20110182963 | OSTEOIMPLANT AND METHODS FOR MAKING - An osteoimplant is disclosed and includes a plurality of partially demineralized fibers. Each fiber has an elongated, thin body having a length of about 1 centimeter to about 3 centimeters. Further, the plurality of fibers engages to establish a matrix of material. The disclosure is further directed to a method of making the above-mentioned osteoimplant. | 2011-07-28 |
20110182964 | Vascular Stent Which Elutes Amino Acid-Methyl-Ester Derivatives for the Treatment of Vulnerable Plaque and Vascular Disease - This invention provides implantable medical devices that include delivery systems containing amino acid derivatives, and related methods for making and using. More specifically, this invention provides vascular stents with coatings containing methyl ester derivatives of amino acids, and related methods for making and using. | 2011-07-28 |
20110182965 | HIGHLY COMPRESSION RESISTANT MATRIX WITH POROUS SKELETON - A highly compression resistant matrix is provided for implantation at or near a target tissue site beneath the skin. The matrix comprises a polymer and a ceramic skeleton. The compression resistance provides retention of a volume that facilitates bone regeneration. | 2011-07-28 |
20110182966 | INTRACAMERAL SUSTAINED RELEASE THERAPEUTIC AGENT IMPLANTS - Described herein are intracameral implants including at least one therapeutic agent for treatment of at least one ocular condition. The implants described herein are not anchored to the ocular tissue, but rather are held in place by currents and gravity present in the anterior chamber of an eye. The implants are preferably polymeric, biodegradable and provide sustained release of at least one therapeutic agent to both the trabecular meshwork and associated ocular tissue and the fluids within the anterior chamber of an eye. | 2011-07-28 |
20110182967 | IMPLANTS FOR ADMINISTERING SUBSTANCES AND METHODS OF PRODUCING IMPLANTS - A porous silicon implant impregnated with a beneficial substance, such as a micromineral required for healthy physiology, is implanted subcutaneously and is entirely corroded away over the following months/year to release the micromineral in a controlled manner. In a second embodiment the implant may have a large number of holes which contain beneficial substance and which are closed by bio-errordable doors of different thickness so as to stagger the release of the beneficial substance over time as the doors are breached. | 2011-07-28 |
20110182968 | Interpenetrating polymer network hydrogel corneal prosthesis - The present invention provides materials that have high glucose and oxygen permeability, strength, water content, and resistance to protein adsorption. The materials include an interpenetrating polymer network (IPN) hydrogel that is coated with biomolecules. The IPN hydrogels include two interpenetrating polymer networks. The first polymer network is based on a hydrophilic telechelic macromonomer. The second polymer network is based on a hydrophilic monomer. The hydrophilic monomer is polymerized and cross-linked to form the second polymer network in the presence of the first polymer network. In a preferred embodiment, the hydrophilic telechelic macromonomer is PEG-diacrylamide, PEG-diacrylate or PEG-dimethacrylate and the hydrophilic monomer is an acrylic-based monomer. Any biomolecules may be linked to the IPN hydrogels, but are preferably biomolecules that support the growth of cornea-derived cells. The material is designed to serve as a corneal prosthesis. | 2011-07-28 |
20110182969 | THIN FILM WITH NON-SELF-AGGREGATING UNIFORM HETEROGENEITY AND DRUG DELIVERY SYSTEMS MADE THEREFROM - The invention relates to film products containing desired levels of active components and methods of their preparation. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. Desirably, the films may be exposed to temperatures above that at which the active components typically degrade without concern for loss of the desired activity. | 2011-07-28 |
20110182970 | Nitric oxide sensors and systems - The present disclosure relates to nitric oxide sensors and systems. | 2011-07-28 |
20110182971 | TRANSEPIDERMAL DRUG DELIVERY SYSTEM CONTAINING TULOBUTEROL - Disclosed is a pharmaceutical composition containing tulobuterol. More specifically, disclosed is a transepidermal drug delivery system including a drug layer containing tulobuterol and a natural rubber-based adhesive material, and a supporter adhered to one surface of the drug layer to support the drug layer, wherein the natural rubber-based adhesive material comprises 10 to 40 parts by weight of a natural rubber, 54.5 to 85 parts by weight of a rosin ester resin and an acid value controller, and the drug layer has a thickness of 25 μm to 75 μm. | 2011-07-28 |
20110182972 | LOW-CONCENTRATION CAPSAICIN PATCH AND METHODS FOR TREATING NEUROPATHIC PAIN - Described here are patches and methods for treating neuropathic pain. In some variations, the neuropathic pain-relieving patch comprises capsaicin or a capsaicin analog, wherein the concentration of the capsaicin or capsaicin analog is less than 1% by weight, and a penetration enhancer, wherein the patch is capable of relieving neuropathic pain over a sustained period of time. The penetration enhancer may be any suitable penetration enhancer. The patches may also include oils, viscosity increasing agents, and the like. In some variations, the pain-relieving patches comprise capsaicin, or an, wherein the concentration of the capsaicin or analog is less than 1%, and a penetration enhancer, whereby delivery of capsaicin from the patch continues for at least an hour, and whereby a single use of the patch provides a therapeutic benefit for at least one month, two months, or three months. Methods for treating neuropathic pain are also described. | 2011-07-28 |
20110182973 | POLYMERASE INHIBITORS AND THE USE THEREOF FOR THE TREATMENT OF TUMORS - The invention relates to polymerase inhibitors, particularly polymerase alpha inhibitors, and the use thereof in the treatment of cell growth disorders, particularly tumor disorders, preferably actinic keratoses, basal cell carcinomas, and/or spinocellular carcinomas. | 2011-07-28 |
20110182974 | MULTIMERIC MULTIEPITOPE INFLUENZA VACCINES - The present invention relates to multimeric multi-epitope peptide-based vaccines. In particular, the present invention relates to the use of multimeric multi-epitope peptide-based vaccines eliciting protective immunity to influenza. | 2011-07-28 |
20110182975 | METHOD OF CONFERRING A PROTECTIVE IMMUNE RESPONSE TO NOROVIRUS - The present invention relates to vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to methods of conferring protective immunity to Norovirus infections in a human subject. | 2011-07-28 |
20110182976 | LIPOPLEX-PATCH BASED DNA VACCINE - This invention relates to a DNA vaccine preparation in a patch against virus infection comprising a DNA construct incorporated in a liposome, wherein the ratio of DNA to liposome is from 1:1 to 1:10; wherein the DNA vaccine preparation is preferably administrated after a pretreatment with alpha hydroxyl acids. | 2011-07-28 |
20110182977 | TOPICAL COMPOSITION CONTAINING IBUPROFEN - The present invention generally relates to the transdermal delivery of various compositions. In some aspects, the transdermal delivery may be facilitated by the use of a hostile biophysical environment. One set of embodiments provides a composition for topical delivery comprising ibuprofen and/or an ibuprofen salt, a nitric oxide donor, and optionally, a hostile biophysical environment. In some cases, the composition may be stabilized using a stabilization polymer such as xanthan gum, KELTROL® BT and/or KELTROL® RD; propylene glycol; and a polysorbate surfactant such as Polysorbate 20, which unexpectedly provides temperature stability to the composition, e.g., at elevated temperatures such as at least 40° C. (at least about 104° F.), as compared to compositions lacking one or more of these. | 2011-07-28 |
20110182978 | ACTIVATED NITRIC OXIDE DONORS AND METHODS OF MAKING AND USING THEREOF - Described herein are compositions useful in anticancer treatment and prevention. The compositions are composed of (a) an O | 2011-07-28 |
20110182979 | In-Vivo Non-Viral Gene Delivery of Human Vascular Endothelial Growth Factor Following Islet Transplantation - An ultrasound-mediated gene transfer method named Ultrasound Targeted Microbubble Destruction (UTMD) for the delivery of human vascular endothelial growth factor (hVEGF) gene to transplanted islets and the surrounding tissue is described herein. The delivery of hVEGF promotes islet revascularization and survival. The inventors, first transplanted human islets were transplanted into diabetic nude mice liver followed by the induction of non-viral plasmid vectors encoding hVEGF or Green Fluorescent Protein (GFP) gene in the host liver by UTMD. Transplantation without gene delivery was also performed as a control. Blood glucose, serum human insulin, C-peptide levels and the revascularization in graft islets were evaluated. The findings of the method of the present invention indicated that hVEGF gene delivery to host liver using UTMD promoted islet revascularization after islet transplantation and improved the restoration of euglycemia. | 2011-07-28 |
20110182980 | COMPOSITION FOR SUPPRESSING EXPRESSION OF TARGET GENE - An object of the present invention is to provide a composition for suppressing expression of a target gene, and the like. A composition comprising an RNA-encapsulated liposome, wherein the RNA contains a sequence consisting of 15 to 30 contiguous bases of a target gene mRNA (hereinafter, sequence X) and a base sequence (hereinafter, complementary sequence X′) complementary to the sequence X, 1 to 90% of all sugars binding to the bases of the sequence X and the complementary sequence X′ being ribose substituted by a modifying group at 2′ position, and the lipid particle being capable of reaching a tissue or an organ containing an expression site of the target gene is provide. | 2011-07-28 |
20110182981 | GONOCOCCAL VACCINES - The present invention relates to immunogenic compositions comprising a recombinant | 2011-07-28 |
20110182982 | LIPOSOME TREATMENT OF VIRAL INFECTIONS - One can treat a viral infection such as hepatitis B (HBV), hepatitis C(HCV), and bovine viral diarrhea virus (BVDV) infections via the delivery of pH sensitive liposomes directly into the endoplasmic reticulum (ER) membrane. Two exemplary liposome formulations are DOPE/CHEMS (DC liposomes) and DOPE/CHEMS/PEG-PE (DCPP liposomes). DC and DCPP liposomes can optimize the intracellular delivery of N-butyl deoxynojirimycin (NB-DNJ), and consequently increase the in vivo activity of this iminosugar several orders of magnitude, and could be used in combination with other therapeutic agents such as interferon and/or ribavirin. The optimized release of NB-DNJ directly into the ER can be also applied for the treatment of other viruses, for which NB-DNJ is known to be an effective antiviral, such as human immunodeficiency virus (HIV). | 2011-07-28 |
20110182983 | HUMAN IMMORTALISED NEURAL PRECURSOR CELL LINE - The present invention relates to an immortalised human neural precursor cell line, NGC-407. The cell line has been established from human foetal tissue. The cell line has been immortalised using a retroviral vector containing the v-myc oncogene. The cell line is a neural progenitor cell line capable of differentiating into to astrocytes and neurons including dopaminergic neurons. NGC-407 cells are capable of migrating to glioblastoma tumours implanted into rat brains and form gap junctions with the tumour cells. NGC-407 cells expressing a suicide gene can be be used for delivering activated prodrugs in the form of activated nucleoside analogs to tumours. | 2011-07-28 |
20110182984 | High Content Sodium Ibuprofen Granules, Their Preparation And Their Use In Preparing Non-Effervescent Solid Dosage Forms - Granules of racemic sodium ibuprofen dihydrate formed from components specified herein have very desirable properties and can be effectively used in conventional rotary press tableting equipment without operational difficulties often encountered in actual practice. Their preparation by a wet granulation process, the wet granule compositions, formulations adapted for preparation of solid dosage forms utilizing a rotary press, solid dosage forms, and methods of preparing solid dosage forms in a rotary press are also described. | 2011-07-28 |
20110182985 | Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof - The present invention provides pharmaceutical compositions which are effective in providing therapeutically effective blood levels of a therapeutically active ingredient to a subject when administered to a gastrointestinal tract. In one aspect, the pharmaceutical compositions comprise a therapeutically effective amount of a therapeutically active ingredient; at least one water soluble enhancer, e.g., a medium chain fatty acid or a salt, ester, ether, or derivative of a medium chain fatty acid and has a carbon chain length of from about 4 to about 20 carbon atoms; and a saccharide. | 2011-07-28 |
20110182986 | CONTROLLED RELEASE COMPOSITION - An improved composition for controlling the release profile of an active compound through the intestinal tract comprises particles, especially pellets, containing the active compound, which are coated with a pH dissolution dependent coating material or a polymethacrylate material, which is preferably pH dissolution dependent, to a certain thickness depending upon the location and rate of release of the active compound that is desired. In preferred compositions, two or more pluralities of particles, in which particles of each plurality are coated with pH dissolution dependent coating material or polymethacrylate material to a different thickness to those of each other plurality, are contained within an enterically coated capsule and provide release of the active compound at various desired locations in the intestinal tract. | 2011-07-28 |
20110182987 | PHARMACEUTICAL DOSAGE FORM FOR THE SITE-SPECIFIC DELIVERY OF MORE THAN ONE ACTIVE PHARMACEUTICAL INGREDIENT - This invention relates to a pharmaceutical dosage form for the site specific delivery of more than one active pharmaceutical ingredient to different sites in the human or animal body in the gastrointestinal tract. The dosage form has an outer polymeric layer incorporating a first active pharmaceutical ingredient which reacts to stimuli specific in the stomach, degrades, and releases the first active pharmaceutical ingredient in the stomach for absorption. The dosage form also has at least one inner polymeric layer incorporating a second active pharmaceutical ingredient which, once the outer layer has degraded, passes into the intestine where the polymers of the second layer degrade to release the second active pharmaceutical ingredient. The dosage form may have additional layers each incorporating active pharmaceutical ingredients for release in different portions of the intestine depending on the nature of the polymers. | 2011-07-28 |
20110182988 | GASTRORETENTIVE PHARMACEUTICAL DOSAGE FORM - This invention relates to an orally administrable, gastroretentive pharmaceutical dosage form which contains at least one pharmaceutically active ingredient and at least one polymeric adjuvant. The adjuvant serves to retain the dosage form in a selected region of the gastrointestinal tract for sufficient time for the pharmaceutically active ingredient to be released and absorbed. Ideally the dosage form will contain two or more pharmaceutically active ingredients which are delivered to different regions of the gastrointestinal tract. | 2011-07-28 |
20110182989 | COMPOSITIONS AND METHODS FOR INHIBITING CELLULAR ADHESION OR DIRECTING DIAGNOSTIC OR THERAPEUTIC AGENTS TO RGD BINDING SITES - Compounds comprising R-G-Cysteic Acid (i.e., R-G-NH—CH(CH | 2011-07-28 |
20110182990 | NANOCOMPOSITE HYDROGEL AND METHOD FOR PREPARING IT, FOR INDUSTRIAL AND MEDICAL APPLICATIONS - Nanocrystalline cellulose (NCC) is employed as the cross-linker and reinforcement domain for developing nanocomposite hydrogels possessing high strength and improved diffusion property; the resulting nanocomposite hydrogels are shown to have high mechanical properties, reversible swelling ability, and are biodegradable and biocompatible; the approach relies on free radical polymerization to form the hydrogels using a variety of hydrophilic vinyl monomers. These hydrogels are suitable for developing highly absorbent hygiene products, as well as for applications in medicine, engineering materials and sensors. | 2011-07-28 |
20110182991 | METHOD FOR IMPROVED FIBRIN SEALING - The present invention relates to a fibrin matrix, its preparation and use for effectively sealing a defect in a mucosa or other moist tissue. | 2011-07-28 |
20110182992 | PEPTIDES AND PEPTIDE MIMETICS TO TREAT PATHOLOGIES ASSOCIATED WITH EYE DISEASE - This invention provides novel active agents (e.g. peptides, small organic molecules, amino acid pairs, etc.) peptides that ameliorate one or more symptoms of eye disease and/or other pathologies characterized by an inflammatory response, hi certain embodiment, the peptides resemble a G* amphipathic helix of apolipoprotein J. The agents are highly stable and readily administered via an oral route or via intraocular injection. | 2011-07-28 |
20110182993 | FILM-FORM PREPARATION - An object of the present invention is to provide a film-form preparation to be used in desensitization therapy and a method for producing the same. This film-form preparation enables the patient to self-administer an allergen and adjust the dose, has excellent portability, has no residual sensation, provides excellent protection against accidental swallowing, is easy for a caregiver to administer, and can greatly improve the QOL of both patients and caregivers. Additionally, this film-form preparation enables arbitrary control of the dissolution time in the mouth, particularly sublingually and has very little gummy sensation in the mouth and better feeling when touched by the fingers. A film-form preparation including: an allergen; an edible polymer that is soluble in both water and a polar organic solvent; and one or two or more types of particles selected from the group consisting of monosaccharide to hexasaccharide sugars and sugar alcohols thereof that have an average particle size of 0.1 to 100 μm. | 2011-07-28 |
20110182994 | METHODS AND SYSTEMS FOR PRODUCTION OF NANOPARTICLES - Methods and systems for preparing nanoparticles. A source of a carrier fluid is connected to an inlet of a flow conduit, such as an intravenous solution administration tube with injection ports, such that the carrier fluid flows through the conduit. A substance (e.g., a drug solution or other substance solution) is introduced into the conduit at a first location causing substance nanoparticles to form within and continue to flow thought he conduit. A stabilizer is introduced into the conduit at a second location to cause a stabilizing effect on the nanoparticles. In some embodiments, the stabilizer may limit or deter agglomeration or growth of the nanoparticles, thereby limiting the size of the nanaparticles produced. | 2011-07-28 |
20110182995 | MEDICAL AND DENTAL BIOMATERIAL AND METHOD OF USE FOR THE SAME - The embodiments herein provide a dental and medical biomaterial and its use for sealing and/or filling the tooth and bone cavities. In the embodiments herein, the calcium salt, calcium oxide, calcium silicate, and calcium phosphate compounds are mixed with a water-base solution, and a bioactive phosphate and calcium enriched mixture is prepared. The mixture comprises high concentration of water-soluble calcium and phosphate, and consequently forms hydroxyapatite during and after setting. The dental/medical biomaterial is biocompatible, antibacterial and capable of forming an effective seal against reentrance of microorganisms into the filled cavity. The biomaterial is compatible to handle and set in an aqueous environment and to stimulate soft/hard tissue healing/generation/regeneration. | 2011-07-28 |
20110182996 | SURFACE MODIFIED NANOPARTICLES, METHODS OF THEIR PREPARATION, AND USES THEREOF FOR GENE AND DRUG DELIVERY - A composition comprises a surface modified nanoparticle comprising a core comprising a material selected from the group consisting of organic materials, organometallic materials, inorganic materials, metals, metal oxides, and combinations thereof; and a surface branch covalently linked to the core having the general formula (3): | 2011-07-28 |
20110182997 | SUSPENSION FORMULATIONS - The present invention relates to suspension formulations, especially those for delivering a pharmaceutically active agent in aerosol form using a spray or aerosol device, such as a pressurised metered dose inhaler (pMDI). The formulations may be for pulmonary, nasal, buccal or topical administration, but are preferably for pulmonary inhalation. | 2011-07-28 |
20110182998 | MICROSPHERES USEFUL FOR THERAPEUTIC VASCULAR EMBOLIZATION - Provided herein, for example, are microspheres comprising a gelatin or gelatin substitute and a copolymer of a N-tris-hydroxymethyl methylacrylamide monomer unit, a diethylaminoethylacrylamide monomer unit and a N,N-methylene-bis-acrylamide monomer unit. Also provided are methods of producing microspheres comprising a gelatin or gelatin substitute and a copolymer of a N-tris-hydroxymethyl methylacrylamide monomer unit, a diethylaminoethylacrylamide monomer unit and a N,N-methylene-bis-acrylamide monomer unit. Further provided herein, for example, are compositions comprising the microspheres and methods of using the microspheres and compositions thereof. | 2011-07-28 |
20110182999 | CERAMIDE DISPERSION AND METHOD FOR PRODUCING SAME - The present invention provides a ceramide dispersion which includes (1) ceramide-containing particles which contains a ceramide, which are dispersed in an aqueous phase as an oil-phase component, and which have a volume average particle diameter from 1 nm to 100 nm; and (2) a fatty acid component which is at least one of a fatty acid having a melting temperature not higher than 30° C. or a fatty acid salt; the amount of nonionic surfactant being 0 or not more than 0.1 times the total mass of the ceramide; the amount of an ionic surfactant other than the fatty acid component being 0 or less than 0.05 times the total mass of the ceramide; and the pH being from 6 to 8. | 2011-07-28 |
20110183000 | ARTIFICIAL BONE MATERIAL HAVING CONTROLLED CALCIUM ION ELUTION - Disclosed is an artificial bone material having controlled calcium ion elution, which does not induce cytotoxicity or any inflammatory response. It is found that the elution of a calcium ion from an artificial bone material for transplantation which contains a calcium-containing substance can be prevented effectively by subjecting the carrier to a surface treatment or adding a surface-treating agent to the carrier. It is also found that the induction of cytotoxicity can be prevented and the induction of an inflammatory response can also be prevented by using the above-mentioned carrier having controlled calcium ion elution. | 2011-07-28 |
20110183001 | COMPOSITIONS AND METHODS FOR IMPLANTATION OF ADIPOSE TISSUE AND ADIPOSE TISSUE PRODUCTS - The invention provides compositions and methods for the preparation of biocompatible biomaterials from adipose tissue. Biocompatible biomaterials are cellular or acellular biomaterials. The invention further provides methods of use of the biocompatible biomaterials. | 2011-07-28 |
20110183002 | Composition and method for treating ulcers - The composition for the treatment of ulcers includes ground charcoal, ground mustard seed and an edible salt dissolved or suspended in an edible oil. A single effective therapeutic dosage of the composition includes approximately 4,000 mg of the ground charcoal, approximately 2,500 mg of the ground mustard seed, approximately 550 mg of the edible salt, and approximately 15 ml of the edible oil. The effective therapeutic dosage is delivered to the patient orally, and may be provided to the patient as a tablet or capsule, or as a liquid mixture. | 2011-07-28 |
20110183003 | Liquid oral care product geared to disinfect and sterilize a toothbrush head in a collapsible condiment like package - The invention relates to an oral care liquid composition in a unique collapsible, air-tight, condiment like package geared toward sterilize and disinfect a toothbrush head. | 2011-07-28 |
20110183004 | REPELLING AGENT, BITE REPELLING AGENT AND ARTHROPOD-BORNE DISEASE PREVENTIVE AGENT - The invention provides a measure that can readily prevent arthropod-borne diseases such as malaria that are contracted by 3 to 5 hundred million people worldwide yearly and that cause death of as many as 1.5 to 2.7 million people. By spraying in advance on the skin an arthropod-borne disease preventive agent or the like comprising chlorine dioxide as an effective component thereof, it is possible to provide repelling effect against arthropods such as infected mosquitoes that bear malaria protozoa and also to prevent biting of the skin by the arthropod, thus reducing contraction of the arthropod-borne diseases. | 2011-07-28 |
20110183005 | PROCESS FOR THE PREPARATION OF CONCENTRATED SOLUTIONS OF STABILIZED HYPOBROMITES - The invention provides stabilized concentrated aqueous solutions of alkali hypobromites, as well as a process for the preparation of said stabilized concentrated solutions at low temperatures, comprising reacting a concentrated alkali hydroxide aqueous solution with bromine, adding to the non-stabilized reaction product an aqueous solution of a sulfamic compound to stabilize the hypobromite, and oxidizing bromide to produce additional hypobromite. | 2011-07-28 |
20110183006 | COMPOSITIONS AND METHODS FOR TREATING OSTEOARTHRITIS - The present invention provides compositions and methods for treatment of abnormal conditions in a subject, wherein the abnormal condition affects the musculoskeletal joints of the subject. | 2011-07-28 |
20110183007 | ANTIFUNGAL COMPOSITIONS - An antifungal composition includes a borate fungicide and an ion-exchange type antimicrobial agent with two or more different metal ions. For example, the ion-exchange type antimicrobial agent may be a zeolite and the metal ions may be magnesium ions and manganese ions. The combination of the metal ions and the borate provide a synergistic effect in fungal resistance. | 2011-07-28 |
20110183008 | Lactoferrin - A pure lactoferrin polypeptide containing no more than two metal ions per molecule, or a mixture of the polypeptide and a fragment thereof. The polypeptide or the mixture stimulates skeletal growth and inhibits bone resorption. Also disclosed is a method of treating a bone-related disorder with the polypeptide or the mixture. | 2011-07-28 |
20110183009 | Mazindol Combination In The Treatment Of Attention-Deficit/Hyperactivity - The present invention relates to the field of human health, and more particularly to the treatment of attention deficit/hyperactivity disorder (ADHD) with mazindol. The latter can be administered as monotherapy or in combination with one or more compounds, including psychostimulants, for the indication of ADHD and associated or co-morbid symptoms. | 2011-07-28 |
20110183010 | CARDIOPLEGIC PREPARATION - The present invention relates to a cardioplegic preparation. According to a preferred embodiment of the invention, the preparation is made of two solutions, the first containing magnesium sulfate, potassium and xylitol, and the other containing procaine. | 2011-07-28 |
20110183011 | COMPOSITION AND METHOD FOR TOPICAL TREATMENT OF SKIN LESIONS - Disclosed herein is a composition containing a high concentration of PG is unexpectedly capable of quickly killing other bacteria, fungi, and/or virus in vitro that is indicative of its potential high efficacy in treating various skin infection. Embodiments disclosed herein relate to a composition and method for effective topical treatment of inflammatory skin lesions in mammals, comprising of a high concentration of propylene glycol alone, or in combination with an astringent. The PG at high concentrations can be regarded as an extremely effective, safe, topical, universal, microbicide. | 2011-07-28 |
20110183012 | Pesticidal Mixtures - Pesticidal mixtures comprising, as active components,
| 2011-07-28 |
20110183013 | Herbal composition for improving skin quality and method for making the same - An herbal composition for improving skin quality and a method for making the herbal composition are proposed. The herbal composition is obtained by mixing vinegar and a small amount of sulfur into a primary composition, adding a secondary composition for soaking, and then filtering residues. The method includes steps of: (a) adding vinegar into a soaking container; (b) adding a small amount of sulfur into the soaking container; (c) adding a secondary composition into the soaking container; and (d) filtering residues of those added into and soaked in the soaking container previously so as to obtain the herbal composition. | 2011-07-28 |
20110183014 | PRODUCT CONTAINING EXTRACT FROM ZANTHOXYLUM AVICENNAE (LAM.) DC., AND PREPARATION PROCESS AND USE THEREOF - Disclosed herein are a product containing an extract from | 2011-07-28 |
20110183015 | Medical composition for inhibiting the growth of cancer stem cell - A medical composition for inhibiting the growth of cancer stem cells is disclosed. The medical composition is prepared by mixing herbal medicines with water or alcohol, followed by heating and extraction to obtain a filtrate. One of the medical compositions according to the present invention includes: | 2011-07-28 |
20110183016 | Film-forming liquid formulations for drug release to hair and scalp - The present invention is directed to liquid compositions containing chitosan, a chitosan derivative or a physiologically acceptable salt thereof, which form a film after application onto the scalp and/or the hair, which compositions are useful for delivery of actives onto the scalp surface and/or onto the hair. | 2011-07-28 |
20110183017 | INSECT REPELLENT COMPOSITION - The present application provides insect repellent compositions that include lemongrass oil and p-menthane-3,8-diol. Vanillin or a vanillin-type component may also be included in the insect repellent composition. | 2011-07-28 |
20110183018 | Cholesterol Sulfate And Amino Sugar Compositions For Enhancement Of Stratum Corneum Function - The present invention provides compositions containing a mixture of cholesterol sulfate and an exfoliant. The exfoliant can be N-acetyl-D-glucosamine, N-acetylgalactosamine, or a combination thereof. The combination of cholesterol sulfate with the exfoliant surprisingly enhances the skin barrier even though the activity of each of the components is opposite the other. In addition, because of the ability to enhance or repair the skin barrier function, methods of maintaining or improving a healthy skin barrier are included in the present invention by apply to the skin an effective amount of the mixture of cholesterol sulfate with the exfoliant. The mixture can also be useful in treating or preventing damage to the skin, where the damage is caused by a comprised skin barrier function. As a result of improved skin barrier function, the appearance of lines and wrinkles is generally reduced; rough and dry skin conditions are also improved. | 2011-07-28 |
20110183019 | METHODS OF SCREENING FOR AND TREATING AUTISM SPECTRUM DISORDERS AND COMPOSITIONS FOR SAME - Disclosed are methods of screening for an autism spectrum disorder, compositions that inhibit the release of molecules that disrupt the blood-brain barrier, compositions for treating autism spectrum disorders, and methods of treating autism spectrum disorders. | 2011-07-28 |
20110183020 | Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus - A medicinal preparation, a process, a nutritional composition and regenerative and insulin potentiating method for humans and also for mammals for prevention, treatment and management/glycemic control of diabetes mellitus by obtaining optimum glucose level in blood, by administering an extract of | 2011-07-28 |
20110183021 | Compositions Containing Purine Nucleosides and Manganese and Their Uses - This invention encompasses methods of preserving protein function by contacting a protein with a composition comprising one or more purine nucleosides (such as e.g., adenosine or uridine) and an antioxidant (such as e.g., manganese). In addition, the invention encompasses methods of treating and/or preventing a side effect of radiation exposure and methods of preventing a side effect of radiotherapy comprising administration of a pharmaceutically effective amount of a composition comprising one or more purine nucleosides (such as e.g., adenosine or uridine) and an antioxidant (such as e.g., manganese) to a subject in need thereof. The compositions may comprise | 2011-07-28 |
20110183022 | TIRE VULCANIZATION FORMING MOLD - In a tire vulcanization forming mold which is circumferentially divided into a plurality of segment molds, a plurality of circumferential grooves are formed on each segment mold with spaces in a tire width direction; arc-shape mold blocks are detachably fitted respectively in the plurality of circumferential grooves; a plurality of slit grooves are formed on each mold block to open on side surfaces of the mold block; tread pattern forming blades are detachably inserted into these slit grooves in the tire width direction; and coming-off prevention engaging portions are provided on the slit grooves and the blades. Thus, the tire vulcanization forming mold is capable of enabling the blades to be replaced easily with respect to the segment molds. | 2011-07-28 |
20110183023 | METHOD AND PLANT FOR THE MANUFACTURE OF BUILDING PRODUCTS - A plant and method for the manufacture of cementitious products, viz. cast concrete roof tiles (T), the plant comprising a mixing station where the constituents of a cementitious composition, less an air entraining agent, are admixed under atmospheric pressure and further mixed under a partial vacuum of 200 to 340 mBar after the addition of an air entraining agent, the plant also comprising a moulding station where the tiles (T) are cast in a gang-mould before being cured in a conventional autoclave for up to 10 hours at 45° C. The cured concrete roof tiles (T) are de-moulded after curing and conveyed to a surface preparation zone where a primer coat of a water based epoxy and a surface coating of a water based emulsion paint are applied to at least an upper surface (in use) of the cast concrete roof tiles (T). The admixed cementitious composition has a Ford Cup flow of between 40 and 60 seconds and a slump test of between 180 and 220 mm. In an alternative method, instead of applying a primer coat, the upper surfaces, in use, of the roof tiles T are subjected to abrasion by grit-blasting to remove a thin layer from the upper surfaces thereby facilitating the subsequent application thereto of a surface coating. | 2011-07-28 |
20110183024 | APPARATUSES FOR FORMING OBJECTS - An apparatus for forming an object from a dose of plastics comprises a die arrangement provided with a cavity for receiving said dose and with at least two parts that are reciprocally movable for shaping an undercut portion of said object, at least one fluid for applying a clamping force so as to keep said at least two parts in contact; said at least one fluid is such as to increase discontinuously said clamping force from an initial force that is applicable when said dose is substantially contained in said cavity to a final force applicable when said at least two parts shape said undercut portion. | 2011-07-28 |
20110183025 | SCOOP INCORPORATING A HEAT TRANSFER FLUID - A dishwasher safe ice cream scoop is disclosed, the ice cream scoop including a scoop bowl, a handle extending laterally outwardly from connected to the scoop bowl, the handle having a cavity formed therein, a heat transfer fluid disposed in the cavity of the handle, a cap joined with the handle and adapted to seal the cavity of the handle, and a coating formed on at least one of the scoop bowl and the handle to militate against at least one of oxidation, corrosion, and tarnishing. | 2011-07-28 |
20110183026 | Embossing Roll Assembly With Mixed Inclination Embosses - An emboss pattern, tissue product and method of manufacturing tissue product having improved bulk and softness with minimal roll ridging. The pattern combines a plurality of aligned signature bosses with a grouping of signature bosses offset from the machine direction in a clockwise manner and another grouping of signature bosses being offset in a counter-clockwise manner. | 2011-07-28 |
20110183027 | Micro-Conformal Templates for Nanoimprint Lithography - A micro-conformal nanoimprint lithography template includes a backing layer and a nanopatterned layer adhered to the backing layer. The elastic modulus of the backing layer exceeds the elastic modulus of the nanopatterned layer. The micro-conformal nanoimprint lithography template can be used to form a patterned layer from an imprint resist on a substrate, the substrate having a micron-scale defect, such that an excluded distance from an exterior surface of the micron-scale defect to the patterned layer formed by the nanoimprint lithography template is less than a height of the defect. The nanoimprint lithography template can be used to form multiple imprints with no reduction in feature fidelity. | 2011-07-28 |
20110183028 | LABELER FOR LABELING PLASTIC CONTAINERS IN THE BLOW MOLD IN A ROTARY BLOW MOLDER - A labeler for labeling plastic containers in the blow mold in a rotary blow molder, with a blow wheel having arranged thereon a plurality of blow molds with a lowerable blow mold bottom, and at least one label dispenser used for providing tubular labels. The blow mold bottom is implemented such that a label can be introduced via the blow mold bottom into the blow mold before the blowing process takes place, which facilitates a spatial separation of the label supply from the feeder star wheel of the blow wheel and allows a substantially simultaneous insertion of the label and of the preform. | 2011-07-28 |
20110183029 | METHOD AND ARRANGEMENT TO IMPROVE THE PRODUCTION OF A BLADE - A method and an arrangement to improve the production of a blade, preferably to improve the production of a wind turbine blade is provided. A first container includes a resin. The first container is connected with a degas-system, thus the resin is provided to the degas-system. The degas-system is constructed and designed in a way that the amount of gas within the provided resin is reduced. Thus gas-reduced resin is produced, which is mixable with a hardener. The resin-hardener-mixture is applicable for an injection into an enclosed composite structure, which is used to produce the blade. | 2011-07-28 |
20110183030 | Hot-Runner System having Nano-Structured Material - Disclosed is a hot-runner system of an injection molding system, the hot-runner system comprising a hot-runner component, including: a material, and a nano-structured material being combined with the material. | 2011-07-28 |
20110183031 | RANGE OF SHELF STABLE INFANT FOODS WHICH INCLUDE ONLY NATURALLY CONTAINED SUGARS AND METHODS FOR MAKING THE SAME - A range of infant food products comprises a plurality of products wherein each product in the range has less than about 10% total energy of the product provided by added sugar. The resulting range of infant food products has the advantage that each food product in the range has a natural taste which results from the components in the product rather than a sweet taste provided by added sugar. | 2011-07-28 |
20110183032 | Stomach-proected Alpha-amylase to Improve the Utilization of Diet Energy and Growth Performance of Animals - A protected α-amylase is described. Pelletization and encapsulation technology, in which slow-release materials and pH-sensitive materials are used to protect the α-amylase from inactivation at low pH. The protected α-amylase was found to be highly stable after as long as 3-hour treatment in acid (pH 3.0). When treated in pH 3.0 for 1 hour and followed by treatment with lipase and pancreatin in pH 7.0 for 2 hour to simulate in vivo environment, it was found that α-amylase was fully released and measurable. In addition, the protected α-amylase showed superior efficacy to the unprotected α-amylase. The protected α-amylase also demonstrated enhanced thermostability. | 2011-07-28 |
20110183033 | CHIA-BASED FATTY ACIDS FOOD PRODUCT, RICH IN OMEGA-3, WITH GOOD STABILITY - A food product with Chia vegetable oil as a source of essential fatty acids, obtained by a simple and effective micro-encapsulation method using spray drying under special conditions. The product is highly soluble and oxidatively stable (by micro-encapsulation), odorless and flavorless, and can be used in food preparations or can be ingested alone. | 2011-07-28 |
20110183034 | ENHANCEMENT OF MAGENESIUM UPTAKE IN MAMMALS - Disclosed are methods and complexes for increasing magnesium uptake in mammals. Increasing magnesium uptake in mammals is accomplished by concurrently administering one or more magnesium salts with one or more quaternary amines and/or phosphatides and one or more di- or tri-carboxylic acids. | 2011-07-28 |
20110183035 | COOKING METHOD USING AN AUTOMATIC PRESSURE DOUBLE BOILER - A cooking method using an automatic pressure double boiler is provided. The cooking method can prevent steam containing the medicinal or nutritive components in the medicine or health food from leaking out of the cooking pot, and thus keep the medicinal or nutritive effect of the medicine or health food, compared with conventional cooking methods, such as baking with fire, boiling with water, frying with oil, steaming, etc. The cooking method does not allow the boiled water or steam to enter the inner cooking pot, thereby acquiring pure medicinal or nutritive components from the medicine or health food. Since the cooking method heats the medicine or food with the energy of the steam from the boiled water, not direct or conducted heat energy from an electric heater, it cannot burn the medicine or food although it heats it to extract the pure medicinal or nutritive components and condenses them. | 2011-07-28 |
20110183036 | TREATS AND METHODS FOR PRODUCING SAME - Treats have a water activity of less than 0.5 and good organoleptic properties. A method for obtaining such treats having low water activity involves injection molding a dough made from a polyol and at least one of a source of casein and a source of starch. | 2011-07-28 |
20110183037 | Recombinant hexose oxidase, a method of producing same and use of such enzyme - A method of producing hexose oxidase by recombinant DNA technology, recombinant hexose oxidase and the use of such enzyme, in particular in the manufacturing of food products such as doughs and dairy products, animal feed, pharmaceuticals, cosmetics, dental care products and in the manufacturing of lactones. Suitable sources of DNA coding for the enzyme are marine algal species including | 2011-07-28 |
20110183038 | ACIDIFIED NUTRITIONAL FORMULA - A nutritional formula has a pH in the liquid state in the range from 4.8 to 5.2, which formula comprises, on a dry matter basis, lactic acid in an amount of not more than 1.35% and at least 0.5% of a salt of lactic acid (+)-lactic acid for preparing nutritional formulas with a pH in the range of 3.5 to 6. | 2011-07-28 |
20110183039 | PROCESS FOR PRODUCING FROZEN PARTICLES - A process for preparing frozen particles having an average diameter of from 1 to 10 mm and comprising from 1 to 50 wt % of a frozen aqueous core and from 50 to 99 wt % of a fat-based shell is provided, the process comprising: providing a dispensing device having an inner nozzle and an outer nozzle which surrounds the inner nozzle; supplying an aqueous mix to the inner nozzle and a fat-based mix to the outer nozzle, thereby forming particles with a water-continuous core and a fat-continuous shell, and then dropping the particles into a refrigerant. | 2011-07-28 |
20110183040 | Amino Acid and Peptide Products - The present invention relates to a product composition comprising free natural amino acids and short natural peptides of an aquatic animal origin. | 2011-07-28 |
20110183041 | FROZEN CONFECTIONERY HAVING HIGH PROTEIN AND LOW FAT CONTENT - The present invention relates to frozen confectionery product having a protein content of at least 6 wt %, a fat content of at most 8 wt %, an overrun of at least 50% and comprising emulsifiers in an amount of 0.35 to 0.45 wt %. It also relates to the use of emulsifiers in an amount of at least 0.3% for stabilising such frozen confectionery and to a method of improving the stability of frozen confectionery by adding emulsifiers in an amount of 0.35 to 0.45 wt % during preparation of said frozen confectionery. | 2011-07-28 |
20110183042 | Versatile tea infuser - An integral tea infuser apparatus is provided to compress brewed tea leaves. In accordance with one embodiment: a tea infuser apparatus comprises a top member and a bottom member set to slidably mate with each other forming open, closed and compressed positions. The top member has a top tea retainer cover and a top compressor side having a top push-pull handle, and the bottom member has a bottom tea retainer and a bottom compressor side having a bottom push-pull handle. | 2011-07-28 |
20110183043 | PRE-CHARGED GROUND COFFEE CAPSULE - A pre-charged ground coffee capsule is described. The capsule has a container body made of a metal foil material combined with a film of thermoplastic material. The container body is open at one end, the end being joined to a closing surface made of the same material. The container body is associated with a structural stiffening member provided with a plurality of through-openings and arranged in a plane which is substantially perpendicular to a longitudinal axis of the container body. | 2011-07-28 |
20110183044 | FOLDED, EMBOSSED FOOD PRODUCT AND APPARATUS FOR AND METHODS OF PREPARATION - A food item is prepared by depositing food ( | 2011-07-28 |
20110183045 | CEREAL BARS CONTAINING INULIN AND THEIR METHODS OF MANUFACTURE - A cereal bar comprising identifiable ready-to-eat (RTE) cereal pieces; and a carbohydrate binder combined with the cereal pieces, wherein the carbohydrate binder contains inulin is provided. In one embodiment, the cereal bar comprises added protein. A method of making a cereal bar is also provided. | 2011-07-28 |